Sei Investments CO Neuronetics, Inc. Transaction History

Sei Investments CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$2.81 - $6.71 $1,017 - $2,429	362 Added 1.89%	19,533 $56,000
Q1 2022 May 13, 2022	SELL	$2.84 - $4.52 $1,133 - $1,803	-399 Reduced 2.04%	19,171 $58,000
Q3 2021 Nov 12, 2021	BUY	$6.22 - $15.54 $47,477 - $118,616	7,633 Added 63.94%	19,570 $128,000
Q2 2021 Aug 06, 2021	BUY	$10.15 - $17.25 $121,160 - $205,913	11,937 New	11,937 $191,000
Q3 2018 Nov 08, 2018	SELL	$24.32 - $37.54 $38,425 - $59,313	-1,580 Closed	0 $0

Q2 2018 Aug 03, 2018	BUY	$26.61 - $27.78 $42,043 - $43,892	1,580 New	1,580 $42,000

18.4M

200

3.6K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $49.7M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.